Bone outcomes in virally suppressed youth with HIV switching to tenofovir disoproxil fumarate

Bone outcomes in virally suppressed youth with HIV switching to tenofovir disoproxil fumarate

Background: Tenofovir disoproxil fumarate (TDF) is included in first-line antiretroviral treatment (ART) for adolescents living with HIV (ALWH). Associated toxicities remain a concern. Objective: We evaluated bone and renal safety outcomes in virologically suppressed South African ALWH after switch...

Full description

Bibliographic Details
Main Authors: Kate Braithwaite, Tristan D. McPherson, Yanhan Shen, Stephen Arpadi, Stephanie Shiau, Gillian Sorour, Karl-Günter Technau, Michael T. Yin
Format: Article
Language:English
Published: AOSIS 2021-08-01
Series:Southern African Journal of HIV Medicine
Subjects:
renal
bone
adolescents
tenofovir disoproxil fumarate
south africa
Online Access:https://sajhivmed.org.za/index.php/hivmed/article/view/1243

Internet

https://sajhivmed.org.za/index.php/hivmed/article/view/1243

Similar Items